yohimbine has been researched along with Anxiety Neuroses in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (51.52) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, N; Fricke, K; Jacobsen, T; Krug, H; Vogel, S; Wehkamp, K | 1 |
| Davis, ML; Handelsman, PR; Hofmann, SG; Julian, K; Otto, MW; Powers, MB; Rosenfield, B; Rosenfield, D; Shiekh, M; Smits, JA; Tuerk, P | 1 |
| Lewin, AB; McGuire, JF; Storch, EA | 1 |
| Awodele, O; Eluogu, CO; Ishola, IO | 1 |
| Crespi, F | 1 |
| Holmes, A; Quirk, GJ | 1 |
| Asnaani, A; Gutner, CA; Hofmann, SG; Otto, MW; Smits, JA | 1 |
| GERSHON, S; LANG, WJ | 1 |
| TOPP, G | 1 |
| Brown, JS; Joiner, TE; Perez, M; Sallee, FR; Sethuraman, G | 1 |
| Cameron, OG; Curtis, GC; Hollingsworth, PJ; Nesse, RM; Smith, CB | 1 |
| Griez, E | 1 |
| Gillespie, HK; Henauer, SA; Hollister, LE | 1 |
| Breier, A; Charney, DS; Heninger, GR | 1 |
| Charney, DS; Heninger, GR; Krystal, JH; McDougle, CJ; Price, LH | 1 |
| Bremner, JD; Bronen, RA; Charney, DS; Dey, H; Duncan, J; Innis, RB; Krystal, JH; Ng, CK; Rich, D; Salomon, RM; Soufer, R; Southwick, SM; Staib, LH; Zubal, G | 1 |
| Liu, H; Sallee, FR; Sethuraman, G; Sine, L | 1 |
| Watson, S; Young, AH | 1 |
| Campbell, AM; Diamond, DM; Park, CR | 1 |
| Cameron, O; Grunhaus, LJ; Haskett, RF; Hollingsworth, PJ; Pande, AC; Smith, CB | 1 |
| Giller, EL; Perry, BD; Southwick, SM; Yehuda, R | 1 |
| Cameron, OG; Curtis, GC; Hill, EM; Hollingsworth, PJ; Lee, MA; Smith, CB | 1 |
| Goldman, S; Mendlewicz, J; Papadimitriou, GN; Sevy, S; Surmont, DW | 1 |
| Charney, DS; Heninger, GR; Woods, SW | 1 |
| Charney, DS; Heninger, GR | 4 |
| Paul, SM; Wolkowitz, OM | 1 |
| Nesse, RM; Rainey, JM | 1 |
| Charney, DS; Goodman, WK; Heninger, GR; Woods, SW | 1 |
| Shear, MK | 1 |
| Cameron, OG; Grunhaus, L | 1 |
7 review(s) available for yohimbine and Anxiety Neuroses
| Article | Year |
|---|---|
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.
Topics: Animals; Anxiety Disorders; Behavior Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic; Yohimbine | 2014 |
Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety Disorders; Behavior, Animal; Extinction, Psychological; Fear; Humans; Mice; Receptors, Adrenergic, alpha-2; Yohimbine | 2010 |
Cognitive enhancers for anxiety disorders.
Topics: Animals; Anxiety Disorders; Benzhydryl Compounds; Caffeine; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Extinction, Psychological; Humans; Learning; Modafinil; Neurotransmitter Agents; Nootropic Agents; Translational Research, Biomedical; Yohimbine | 2011 |
Experimental models of anxiety. Problems and perspectives.
Topics: Animals; Anxiety Disorders; Carbon Dioxide; Child; Conditioning, Classical; Disease Models, Animal; Dogs; Epinephrine; Fear; Humans; Individuality; Infant; Infusions, Parenteral; Lactates; Male; Panic; Stress, Psychological; Yohimbine | 1984 |
Neural and molecular mechanisms in anxiety.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Binding, Competitive; Carbolines; Clonidine; Disease Models, Animal; Forecasting; Haplorhini; Humans; Locus Coeruleus; Piperoxan; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Purinergic; Research Design; Yohimbine | 1985 |
Psychobiology of anxiety and anxiety disorders.
Topics: Animals; Anxiety; Anxiety Disorders; Blood Platelets; Caffeine; Carbolines; Carbon Dioxide; Cats; Disease Models, Animal; Epinephrine; Humans; Hyperventilation; Isoproterenol; Lactates; Lactic Acid; Norepinephrine; Panic; Phobic Disorders; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Research Design; Yohimbine | 1985 |
Pathophysiology of panic: a review of pharmacologic provocative tests and naturalistic monitoring data.
Topics: Anxiety Disorders; Arousal; Caffeine; Calmodulin; Carbon Monoxide; Fear; Humans; Imagination; Isoproterenol; Lactates; Lactic Acid; Locus Coeruleus; Panic; Research Design; Respiration; Yohimbine | 1986 |
9 trial(s) available for yohimbine and Anxiety Neuroses
| Article | Year |
|---|---|
The effects of hydrocortisone and yohimbine on human behavior in approach-avoidance conflicts.
Topics: Anxiety Disorders; Female; Humans; Hydrocortisone; Male; Testosterone; Yohimbine | 2023 |
Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
Topics: Adult; Anxiety Disorders; Combined Modality Therapy; Extinction, Psychological; Fear; Female; Humans; Implosive Therapy; Male; Treatment Outcome; Yohimbine | 2014 |
The illusion of mental health: in the mind of which beholder?
Topics: Adolescent; Anxiety Disorders; Child; Female; Growth Hormone; Humans; Hydrocortisone; Male; Multivariate Analysis; Reproducibility of Results; Self-Assessment; Yohimbine | 2005 |
Yohimbine and the model anxiety state.
Topics: Adult; Anxiety Disorders; Blood Pressure; Dose-Response Relationship, Drug; Emotions; Female; Humans; Male; Middle Aged; Personality Inventory; Placebos; Pulse; Yohimbine | 1984 |
Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
Topics: Adult; Alcohol Drinking; Alcoholic Intoxication; Anxiety Disorders; Blood Pressure; Ethanol; Female; Humans; Hydrocortisone; Injections, Intravenous; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Time Factors; Yohimbine | 1995 |
Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder.
Topics: Anxiety Disorders; Brain; Brain Chemistry; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Tomography, Emission-Computed; Yohimbine | 1997 |
Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
Topics: Adult; Anxiety Disorders; Arousal; Blood Pressure; Brain; Clinical Trials as Topic; Female; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Panic; Psychological Tests; Receptors, Adrenergic; Yohimbine | 1989 |
Alpha 2-adrenergic and opiate receptor blockade. Synergistic effects on anxiety in healthy subjects.
Topics: Adult; Anxiety Disorders; Drug Synergism; Erectile Dysfunction; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naloxone; Receptors, Adrenergic, alpha; Receptors, Opioid; Yohimbine | 1986 |
Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Pressure; Clonidine; Fear; Female; Growth Hormone; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Panic; Placebos; Posture; Receptors, Adrenergic, alpha; Sleep; Sympathetic Nervous System; Yohimbine | 1986 |
17 other study(ies) available for yohimbine and Anxiety Neuroses
| Article | Year |
|---|---|
Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Male; Mangifera; Metergoline; Mice; Phytotherapy; Plant Bark; Plant Extracts; Plant Stems; Receptors, Adrenergic, alpha-2; Receptors, Biogenic Amine; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Sulpiride; Yohimbine | 2016 |
Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Disease Models, Animal; Electrophysiology; Locus Coeruleus; Male; Neurons; Neuropharmacology; Neurophysiology; Norepinephrine; Rats; Receptors, Adrenergic, alpha-2; Yohimbine | 2009 |
Effects of psychoactive drugs on yohimbine induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood; Blood Pressure; Blood Pressure Determination; Dogs; Yohimbine | 1963 |
[TRIALS OF SEDAPON IN GYNECOLOGY AND OBSTETRICS WITH WARD PATIENTS].
Topics: Adolescent; Anxiety; Anxiety Disorders; Atropa belladonna; Drug Therapy; Female; Genital Diseases, Female; Geriatrics; Gynecology; Humans; Meprobamate; Obstetrics; Pregnancy; Pregnancy Complications; Yohimbine | 1964 |
Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.
Topics: Adolescent; Adult; Anxiety Disorders; Blood Platelets; Catecholamines; Clonidine; Dopamine; Epinephrine; Fear; Female; Humans; Imipramine; Male; Norepinephrine; Panic; Radioligand Assay; Receptors, Adrenergic, alpha; Yohimbine | 1984 |
Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Topics: Adult; Aged; Agoraphobia; Anxiety Disorders; Blood Pressure; Fear; Heart Rate; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Pulse; Receptors, Adrenergic; Yohimbine | 1984 |
Yohimbine challenge in children with anxiety disorders.
Topics: Administration, Oral; Adult; Affect; Age Factors; Anxiety Disorders; Anxiety, Separation; Blood Pressure; Child; Dose-Response Relationship, Drug; Female; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Male; Prolactin; Surveys and Questionnaires; Yohimbine | 2000 |
Yohimbine for anxiety disorders.
Topics: Adrenergic alpha-Antagonists; Anxiety Disorders; Child; Confounding Factors, Epidemiologic; Human Growth Hormone; Humans; Hydrocortisone; Research Design; Treatment Outcome; Yohimbine | 2001 |
Chronic psychosocial stress impairs learning and memory and increases sensitivity to yohimbine in adult rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Anxiety Disorders; Behavior, Animal; Chronic Disease; Disease Models, Animal; Exploratory Behavior; Habituation, Psychophysiologic; Male; Maze Learning; Memory; Rats; Rats, Sprague-Dawley; Stress, Psychological; Yohimbine | 2001 |
Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
Topics: Adult; Anxiety Disorders; Binding, Competitive; Blood Platelets; Clonidine; Depressive Disorder; Fear; Female; Humans; Male; Panic; Psychiatric Status Rating Scales; Receptors, Adrenergic; Yohimbine | 1990 |
Altered platelet alpha 2-adrenergic receptor binding sites in borderline personality disorder.
Topics: Anxiety Disorders; Benzodiazepines; Blood Platelets; Borderline Personality Disorder; Depressive Disorder; Diagnosis, Differential; Humans; Psychiatric Status Rating Scales; Receptors, Adrenergic, alpha; Yohimbine | 1990 |
Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
Topics: Adult; Agoraphobia; Anxiety Disorders; Arousal; Blood Platelets; Blood Pressure; Clonidine; Epinephrine; Fear; Female; Heart Rate; Humans; Male; Norepinephrine; Panic; Receptors, Adrenergic; Yohimbine | 1990 |
Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.
Topics: Adult; Aged; Anxiety Disorders; Blood Platelets; Depressive Disorder; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychological Tests; Receptors, Adrenergic; Yohimbine | 1989 |
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Brain; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Receptors, Adrenergic, alpha; Receptors, GABA-A; Sympathetic Nervous System; Synaptic Transmission; Time Factors; Yohimbine | 1985 |
Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Pressure; Brain; Female; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Psychiatric Status Rating Scales; Psychotherapy, Group; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Synaptic Transmission; Time Factors; Yohimbine | 1985 |
Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Topics: Adult; Anxiety Disorders; Blood Pressure; Fear; Female; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Panic; Receptors, Adrenergic, alpha; Yohimbine | 1987 |
Anxiety and sexual arousal.
Topics: Adult; Anxiety Disorders; Female; Humans; Libido; Yohimbine | 1985 |